Curbing gastrointestinal infections by defensin fragment modifications without harming commensal microbiota.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Marina C Pils, Marina C.
Nisar P Malek, Nisar P.
Heike Brötz-Oesterhelt, Heike
MetadataShow full item record
AbstractThe occurrence and spread of multidrug-resistant pathogens, especially bacteria from the ESKAPE panel, increases the risk to succumb to untreatable infections. We developed a novel antimicrobial peptide, Pam-3, with antibacterial and antibiofilm properties to counter this threat. The peptide is based on an eight-amino acid carboxyl-terminal fragment of human β-defensin 1. Pam-3 exhibited prominent antimicrobial activity against multidrug-resistant ESKAPE pathogens and additionally eradicated already established biofilms in vitro, primarily by disrupting membrane integrity of its target cell. Importantly, prolonged exposure did not result in drug-resistance to Pam-3. In mouse models, Pam-3 selectively reduced acute intestinal Salmonella and established Citrobacter infections, without compromising the core microbiota, hence displaying an added benefit to traditional broad-spectrum antibiotics. In conclusion, our data support the development of defensin-derived antimicrobial agents as a novel approach to fight multidrug-resistant bacteria, where Pam-3 appears as a particularly promising microbiota-preserving candidate.
CitationCommun Biol. 2021 Jan 8;4(1):47. doi: 10.1038/s42003-020-01582-0.
AffiliationHZI,Helmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7,38124 Braunschweig, Germany.
The following license files are associated with this item:
- Creative Commons
- Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent against Multidrug-Resistant Bacteria in a Murine Model of Sepsis.
- Authors: Lee HR, You DG, Kim HK, Sohn JW, Kim MJ, Park JK, Lee GY, Yoo YD
- Issue date: 2020 Apr 14
- Chlortetracycline Enhances Tonsil Colonization and Fecal Shedding of Multidrug-Resistant <i>Salmonella enterica</i> Serovar Typhimurium DT104 without Major Alterations to the Porcine Tonsillar and Intestinal Microbiota.
- Authors: Holman DB, Bearson BL, Allen HK, Shippy DC, Loving CL, Kerr BJ, Bearson SMD, Brunelle BW
- Issue date: 2019 Feb 15
- Antimicrobial polymers as therapeutics for treatment of multidrug-resistant Klebsiella pneumoniae lung infection.
- Authors: Lou W, Venkataraman S, Zhong G, Ding B, Tan JPK, Xu L, Fan W, Yang YY
- Issue date: 2018 Sep 15
- Targeting biofilms and persisters of ESKAPE pathogens with P14KanS, a kanamycin peptide conjugate.
- Authors: Mohamed MF, Brezden A, Mohammad H, Chmielewski J, Seleem MN
- Issue date: 2017 Apr
- A novel smaller β-defensin-derived peptide is active against multidrug-resistant bacterial strains.
- Authors: Colicchio R, Nigro E, Colavita I, Pagliuca C, Di Maro S, Tomassi S, Scaglione E, Carbone F, Carriero MV, Matarese G, Daniele A, Cosconati S, Pessi A, Salvatore F, Salvatore P
- Issue date: 2021 Dec